Description
A potent ETA receptor antagonist (IC50 = 1.4 nM); selective for ETA over ETB receptors (IC50 = 9,800 nM); inhibits endothelin-1-induced phosphoinositol hydrolysis in COS-7 cells (pA2 = 8); reduces blood pressure in a rat model of acute hypoxia-induced pulmonary hypertension (ED50 = 0.5 mg/kg); reduces femoral artery neointimal lesion size in a mouse model of intraluminal injury; decreases BALF pleocytosis, as well as pulmonary collagen deposition and fibrosis, and improves lung mechanics in a mouse model of bleomycin-induced lung injury at 15 mg/kg
Formal name: N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]-3-thiophenesulfonamide, monosodium salt
Synonyms: TBC 11251|Thelin
Molecular weight: 476.9
CAS: 210421-74-2
Purity: ≥98%
Formulation: A solid